Lipocine Inc. (NASDAQ: LPCN) recently filed a Form 8-K with the Securities and Exchange Commission, disclosing updates to its corporate presentation. The document, submitted on January 13, 2025, ...
Day One Biopharmaceuticals, Inc. recently filed a Form 8-K with the Securities and Exchange Commission, providing insights into its financial performance and upcoming priorities. The report, dated ...
As a result, beginning in 2025, Constellium will voluntarily file annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K. In addition, Constellium expects to ...
The Notice has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market. However, if the Company fails to timely regain compliance with the Listing Rule ...
Grayscale Investment has made a compliance move in its crypto investment by filing an 8-K form for the Grayscale Horizen Trust (HZEN) with the U.S. Securities and Exchange Commission (SEC).